Devices › Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing
Device brand name · Attune implant knee tibial tray
Attune Rp Tib Base Sz 4 Cem: medical device reports filed with FDA
603 reports name it, 2015–2025. Manufacturer given most often on reports: Depuy Ireland - 9616671. Product code NJL.
- 603
- device reports naming the brand
- 0% of all MAUDE reports · about 55 a year
- 7
- reports, 12 months to August 2026
- 30 in the 12 months before
- 3.8%
- classified as malfunction
- 3.2% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
603 medical device reports received by FDA name the brand "Attune Rp Tib Base Sz 4 Cem" (attune implant knee tibial tray); the manufacturer given most often on reports is Depuy Ireland - 9616671; received from July 2015 to December 2025. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
7 reports arrived in the 12 months to August 2026, down 77% from 30 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (96.2%) and malfunction (3.8%); across all prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing reports (product code NJL) death is recorded in 0% and malfunction in 3.2%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are loss of or failure to bond (66.3%), migration (7.8%) and loose or intermittent connection (3.2%). The patient problems coded most often are pain, adhesion(s) and joint laxity. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 26,046 reports carrying product code NJL. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Loss of or failure to bond | 400 | 66.3% | 18.4% |
| Migrationthe device moved from where it was placed | 47 | 7.8% | 1.6% |
| Loose or intermittent connection | 19 | 3.2% | 1.1% |
| Loosening of implant not related to bone-ingrowth | 17 | 2.8% | 0.4% |
| Device contaminated during manufacture or shipping | 13 | 2.2% | 0.4% |
| Migration or expulsion of device | 13 | 2.2% | 1.9% |
| Difficult to open or remove packaging material | 12 | 2% | 0.3% |
| Insufficient device problem information | 12 | 2% | 19.8% |
| Malposition of device | 10 | 1.7% | 1% |
| Off-label use | 9 | 1.5% | 0.2% |
| Unintended movement | 7 | 1.2% | 0.9% |
| Loss of osseointegration | 5 | 0.8% | 1.7% |
| Failure to adhere or bond | 4 | 0.7% | 0.2% |
| Inadequacy of device shape and/or size | 2 | 0.3% | 0.5% |
| Naturally worn | 2 | 0.3% | 5.8% |
| Tear, rip or hole in device packaging | 2 | 0.3% | 0.2% |
| Breakthe device broke | 1 | 0.2% | 0.8% |
| Device dislodged or dislocated | 1 | 0.2% | 0.9% |
| Device markings/labelling problema problem with the device markings or label | 1 | 0.2% | 0% |
| Difficult to removethe device was hard to remove | 1 | 0.2% | 0% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Painpain, site not specified | 307 | 50.9% |
| Adhesion(s) | 56 | 9.3% |
| Joint laxity | 37 | 6.1% |
| Not applicable | 35 | 5.8% |
| Edemaswelling from fluid | 29 | 4.8% |
| Loss of range of motion | 29 | 4.8% |
| Synovitis | 22 | 3.6% |
| Swelling/ edema | 18 | 3% |
| Limited mobility of the implanted joint | 16 | 2.7% |
| Muscular rigidity | 14 | 2.3% |
| Discomfortdiscomfort | 13 | 2.2% |
| Falla fall | 13 | 2.2% |
| Injurya physical injury | 11 | 1.8% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 10 | 1.7% |
| Joint disorder | 10 | 1.7% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Attune Rp Tib Base Sz 4 Cem | Product code NJL | All MAUDE reports |
|---|---|---|---|
| Reports | 603 | 26,046 | 26,136,888 |
| Share of that pool | — | 2.3% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 96.2% | 96.8% | 36.2% |
| Classified as malfunction | 3.8% | 3.2% | 62.3% |
| Filed by the manufacturer | 100% | 99.8% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code NJL
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Mbt Cem Keel Tib Tray Sz3 | 1,085 | 9 | 0% |
| Mbt Cem Keel Tib Tray Sz4 | 655 | 4 | 0% |
| Mbt Cem Keel Tib Tray Sz2 5 | 643 | 6 | 0% |
| Attune Rp Tib Base Sz 5 Cem | 613 | 7 | 0% |
| Attune Rp Tib Base Sz 7 Cem | 409 | 7 | 0% |
| Attune Rp Tib Base Sz 6 Cem | 388 | 14 | 0.3% |
| Mbt Cem Keel Tib Tray Sz5 | 371 | 3 | 0% |
| Pfc Sigmarp Stb Tb In 4 10 0 | 328 | 5 | 0% |
| Nexgen Lps-Flex Femoral Component | 502 | 0 | 0% |
| Mbt Cem Keel Tib Tray Sz2 | 296 | 3 | 0% |
| Pfc Sigmarp Stb Tb In 3 10 0 | 302 | 2 | 0% |
| Attune Rp Tib Base Sz 8 Cem | 269 | 4 | 0% |
| Unknown Knee Tibial Insert | 2,247 | 130 | 0.2% |
| Attune Rp Tib Base Sz 3 Cem | 272 | 2 | 0% |
| Lcs Comp Rp Insert Lg 10mm | 241 | 1 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Attune Rp Tib Base Sz 4 Cem reports
How many FDA reports name Attune Rp Tib Base Sz 4 Cem?
603 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 7 in the latest 12 months.
What kinds of events are reported?
injury (96.2%) and malfunction (3.8%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
loss of or failure to bond (66.3%), migration (7.8%), loose or intermittent connection (3.2%), loosening of implant not related to bone-ingrowth (2.8%) and device contaminated during manufacture or shipping (2.2%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Attune Rp Tib Base Sz 4 Cem was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.